These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9506551)

  • 1. Proinflammatory cytokines regulate antigen-independent T-cell activation by two separate calcium-signaling pathways in multiple sclerosis patients.
    Martino G; Grohovaz F; Brambilla E; Codazzi F; Consiglio A; Clementi E; Filippi M; Comi G; Grimaldi LM
    Ann Neurol; 1998 Mar; 43(3):340-9. PubMed ID: 9506551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of interferon gamma on T lymphocytes from patients with multiple sclerosis.
    Grimaldi LM; Martino G
    Mult Scler; 1995; 1 Suppl 1():S38-43. PubMed ID: 9345397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in calcium signaling and cellular responses in septic injury.
    Sayeed MM
    New Horiz; 1996 Feb; 4(1):72-86. PubMed ID: 8689277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
    Bongioanni P; Romano MR; Boccardi B; Lombardo F; Moscato G; Mosti S; Baldini C; Nuti S; Meucci G; Rossi B
    Rev Neurol; 1999 Nov 16-30; 29(10):893-9. PubMed ID: 10637835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.
    Krumbholz M; Theil D; Cepok S; Hemmer B; Kivisäkk P; Ransohoff RM; Hofbauer M; Farina C; Derfuss T; Hartle C; Newcombe J; Hohlfeld R; Meinl E
    Brain; 2006 Jan; 129(Pt 1):200-11. PubMed ID: 16280350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
    Hamamcioglu K; Reder AT
    Mult Scler; 2007 May; 13(4):459-70. PubMed ID: 17463069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-10-modulated immature dendritic cells control the proinflammatory environment in multiple sclerosis.
    Adikari SB; Pettersson A; Soderstrom M; Huang YM; Link H
    Scand J Immunol; 2004 Jun; 59(6):600-6. PubMed ID: 15182256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Fas antigen on T cell subpopulations in peripheral blood of patients with relapsing-remitting multiple sclerosis.
    Bilińska M; Frydecka I; Podemski R; Teodorowska R; Gruszka E
    Med Sci Monit; 2001; 7(2):251-5. PubMed ID: 11257731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
    Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J
    Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulatory role of natural killer cells in multiple sclerosis.
    Takahashi K; Aranami T; Endoh M; Miyake S; Yamamura T
    Brain; 2004 Sep; 127(Pt 9):1917-27. PubMed ID: 15229129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiocidin promotes pro-inflammatory cytokine production and antigen presentation in multiple sclerosis.
    Kremlev SG; Gaurnier-Hausser AL; Del Valle L; Perez-Liz G; Dimitrov S; Tuszynski G
    J Neuroimmunol; 2008 Feb; 194(1-2):132-42. PubMed ID: 18207252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenesis of multiple sclerosis: status of research].
    Hartung HP
    Wien Med Wochenschr; 1996; 146(19-20):520-7. PubMed ID: 9082652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemia inhibitory factor is produced by myelin-reactive T cells from multiple sclerosis patients and protects against tumor necrosis factor-alpha-induced oligodendrocyte apoptosis.
    Vanderlocht J; Hellings N; Hendriks JJ; Vandenabeele F; Moreels M; Buntinx M; Hoekstra D; Antel JP; Stinissen P
    J Neurosci Res; 2006 Apr; 83(5):763-74. PubMed ID: 16477612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
    Ochi H; Feng-Jun M; Osoegawa M; Minohara M; Murai H; Taniwaki T; Kira J
    J Neurol Sci; 2004 Jul; 222(1-2):65-73. PubMed ID: 15240198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis.
    Harp CT; Lovett-Racke AE; Racke MK; Frohman EM; Monson NL
    Clin Immunol; 2008 Sep; 128(3):382-91. PubMed ID: 18599355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal human CD4+ memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis.
    Waldrop SL; Davis KA; Maino VC; Picker LJ
    J Immunol; 1998 Nov; 161(10):5284-95. PubMed ID: 9820501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS.
    Chen M; Chen G; Nie H; Zhang X; Niu X; Zang YC; Skinner SM; Zhang JZ; Killian JM; Hong J
    Eur J Immunol; 2009 Sep; 39(9):2525-36. PubMed ID: 19670379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effector function of type II collagen-stimulated T cells from rheumatoid arthritis patients: cross-talk between T cells and synovial fibroblasts.
    Cho ML; Yoon CH; Hwang SY; Park MK; Min SY; Lee SH; Park SH; Kim HY
    Arthritis Rheum; 2004 Mar; 50(3):776-84. PubMed ID: 15022319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.